Home -> Law Blog Directory -> Patent Law Blogs -> IP ADR Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IP ADR Blog"Patent Troll" Study at Stanford to Get Underway
By Les Weinstein, Michael Young, John Leo Wagner, Eric van Ginkel, and Victoria Pynchon
From the Wall Street Journal's Market Watch, Famed patent firm backs study on touchy subject; Myhrvold, Lemley's study aim for academic neutrality, but some are skepticalBy John Letzing, MarketWatchSAN FRANCISCO (MarketWatch) -- Nathan Myhrvold, a former high-ranking Microsoft Corp. executive turned intellectual property mogul, is sponsoring a forthcoming study that aims to resolve a thorny legal issue: Who's responsible for flooding U.S. courts with a torrent of patent litigation over the past decade?
It's an ambitious project, but one also likely to elicit a good deal of cynicism.
That's because while Myhrvold's firm Intellectual Ventures anticipates fostering companies that turn its intellectual property into products, it hasn't yet. Instead, it's focused on amassing tens of thousands of valuable patents through invention, acquisition and partnering with businesses and universities.
That approach generally defines a firm as a so-called "non-practicing entity," though within the technology industry a more derisive term is often used -- "patent troll."
Big technology companies such as Myhrvold's former employer Microsoft Corporation have long complained that many non-practicing entities not only trade in patents without developing products, but also increasingly use them to target deep-pocketed companies with infringement lawsuits. . . . . .
If the study finds that non-practicing entities have played a relatively minor role in the rise of litigation, it is likely to raise questions, given the involvement of Intellectual Ventures.
"I'm excited to hear what the results are, but when they come out I'll be sure to take them with a grain of salt," said Kelly Hyndman, an intellectual property attorney with Sughrue Mion PLLC.
Full post as published by IP ADR Blog on February 05, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Procrit
Associated with Death in Stroke Study
Xigris
Study Prompts FDA Safety Review
BPA
New Study Shows Link to Diabetes and Heart Disease

Patent Troll Tracker Revealed.
The "real" story on the origin of patent troll
Patent Litigation Down "Bollocks!" Says the Troll Tracker
Cas vécu dune négociation avec un patent troll
Ray Niro Offers $5,000 for Identity of Author of Troll Tracker Blog








